Electsita-DM Tablet ER is a combination medication used in the management of type 2 diabetes mellitus. It contains Dapagliflozin, Metformin, and Sitagliptin, which work together to help control blood sugar levels through different mechanisms. Dapagliflozin helps remove excess glucose from the body through urine, Metformin reduces glucose production in the liver and improves insulin sensitivity, and Sitagliptin enhances the release of insulin while reducing glucagon levels. The extended-release formulation allows gradual release of the medication for sustained blood glucose control throughout the day. When taken as prescribed by a healthcare professional along with proper diet and exercise, Electsita-DM Tablet ER helps maintain stable blood sugar levels and reduce the risk of diabetes-related complications.